Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS).
- People aged between 19 and 45 years old.
- People whose level of disability, as measured by a standard MS scoring tool called the EDSS, falls between 0.5 and 3.5 (confirm with trial site for exact score requirements).
- People who are not currently taking steroid medications, and have not taken corticosteroid treatments within a specified period before joining (confirm with trial site for exact timeframe).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who already have a high level of physical activity in their daily lives.
- People who are currently experiencing an MS relapse, or who have had a relapse within the past 3 months.
- People who have a bone or joint condition that would prevent them from taking part in an exercise program.
- People who have been diagnosed with another nerve or immune system disease in addition to MS.
- People who have started immune-modifying MS treatment within the last 6 months.
- People who have vision problems or are experiencing double vision as a symptom.
- People who have significant muscle stiffness in their legs, rated 3 or 4 on a standard clinical scale called the Modified Ashworth Scale.
- People whose white blood cell count falls outside the normal range of 4,000 to 10,000 cells per microlitre.
- People who have a serious heart or lung condition that would make physical exercise unsafe or unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: seda saka, Assoc. Prof. Dr., Haliç University
Phone: +905550823309
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
CHANGE FROM BASELINE IN SERUM PROINFLAMMATORY CYTOKINE LEVELS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.